Stocks and Investing Stocks and Investing
Wed, June 29, 2022
Tue, June 28, 2022
Mon, June 27, 2022
Fri, June 24, 2022

Marie Thibault Maintained (ABT) at Strong Buy with Decreased Target to $130 on, Jun 24th, 2022


Published on 2024-10-27 21:37:48 - WOPRAI
  Print publication without navigation


Marie Thibault of BTIG, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Decreased Target from $140 to $130 on, Jun 24th, 2022.

Marie has made no other calls on ABT in the last 4 months.



There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 1 agrees with Marie's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold and Held Target at $140 on, Thursday, April 21st, 2022


These are the ratings of the 7 analyists that currently disagree with Marie


  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $145 on, Tuesday, June 7th, 2022
  • Travis Steed of "B of A Securities" Maintained at Strong Buy and Held Target at $140 on, Tuesday, May 31st, 2022
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Tuesday, May 17th, 2022
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $135 on, Thursday, April 21st, 2022
  • Shagun Singh of "RBC Capital" Maintained at Buy with Decreased Target to $143 on, Thursday, April 21st, 2022
  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy and Held Target at $114 on, Sunday, April 10th, 2022
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $150 on, Friday, April 8th, 2022